Literature DB >> 3134899

Phenothiazine-induced systemic lupus erythematosus with superior vena cava syndrome: case report and review of the literature.

V D Steen1, R Ramsey-Goldman.   

Abstract

Phenothiazine-induced lupus with circulating anticoagulant (CAC) has been reported infrequently, and is rarely associated with significant symptoms. We describe a patient who we suspect had perphenazine-induced lupus erythematosus with CAC. She had recurrent episodes of venous thrombosis and ultimately developed superior vena cava syndrome. The relationships among phenothiazine-induced lupus, CAC, and thrombosis are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134899     DOI: 10.1002/art.1780310716

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

Review 1.  Antipsychotic-induced venous thromboembolism: a review of the evidence.

Authors:  Staffan Hägg; Olav Spigset
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 2.  Drug-induced lupus anticoagulants and antiphospholipid antibodies.

Authors:  Jeffrey S Dlott; Robert A S Roubey
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

3.  Quinine induced lupus-like syndrome and cardiolipin antibodies.

Authors:  D Rosa-Re; F García; J Gascon; J Angrill; R Cervera
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

Review 4.  Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management.

Authors:  Anna K Jönsson; Olav Spigset; Staffan Hägg
Journal:  CNS Drugs       Date:  2012-08-01       Impact factor: 5.749

Review 5.  Drug-induced lupus.

Authors:  E J Price; P J Venables
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

6.  Cross-reactive idiotypes in sera from patients with leprosy, lupus and Lyme disease and from healthy individuals.

Authors:  C G Mackworth-Young
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

Review 7.  Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence.

Authors:  Anna K Jönsson; Johan Schill; Hans Olsson; Olav Spigset; Staffan Hägg
Journal:  CNS Drugs       Date:  2018-01       Impact factor: 5.749

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.